pubmed-article:21749389 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21749389 | lifeskim:mentions | umls-concept:C0031715 | lld:lifeskim |
pubmed-article:21749389 | lifeskim:mentions | umls-concept:C0218694 | lld:lifeskim |
pubmed-article:21749389 | lifeskim:mentions | umls-concept:C1157720 | lld:lifeskim |
pubmed-article:21749389 | lifeskim:mentions | umls-concept:C0449560 | lld:lifeskim |
pubmed-article:21749389 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
pubmed-article:21749389 | lifeskim:mentions | umls-concept:C0530937 | lld:lifeskim |
pubmed-article:21749389 | lifeskim:mentions | umls-concept:C0074992 | lld:lifeskim |
pubmed-article:21749389 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:21749389 | pubmed:dateCreated | 2011-7-13 | lld:pubmed |
pubmed-article:21749389 | pubmed:abstractText | Previously, we reported that sphingosine-1-phosphate (S1P) reduced melanin synthesis. In this study we have investigated S1P receptor-mediated extracellular signal-regulated protein kinase (ERK) activation and microphthalmia-associated transcription factor (MITF) phosphorylation. | lld:pubmed |
pubmed-article:21749389 | pubmed:language | eng | lld:pubmed |
pubmed-article:21749389 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21749389 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21749389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21749389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21749389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21749389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21749389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21749389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21749389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21749389 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21749389 | pubmed:month | Mar | lld:pubmed |
pubmed-article:21749389 | pubmed:issn | 2042-7158 | lld:pubmed |
pubmed-article:21749389 | pubmed:author | pubmed-author:FisherDavid... | lld:pubmed |
pubmed-article:21749389 | pubmed:author | pubmed-author:KimDong-SeokD... | lld:pubmed |
pubmed-article:21749389 | pubmed:author | pubmed-author:ParkKyoung-Ch... | lld:pubmed |
pubmed-article:21749389 | pubmed:author | pubmed-author:KwonSun-BangS... | lld:pubmed |
pubmed-article:21749389 | pubmed:author | pubmed-author:MillerArlo... | lld:pubmed |
pubmed-article:21749389 | pubmed:author | pubmed-author:ParkSeo-Hyoun... | lld:pubmed |
pubmed-article:21749389 | pubmed:author | pubmed-author:JeongYun-MiYM | lld:pubmed |
pubmed-article:21749389 | pubmed:copyrightInfo | © 2010 The Authors. JPP © 2010 Royal Pharmaceutical Society. | lld:pubmed |
pubmed-article:21749389 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21749389 | pubmed:volume | 63 | lld:pubmed |
pubmed-article:21749389 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21749389 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21749389 | pubmed:pagination | 409-16 | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:meshHeading | pubmed-meshheading:21749389... | lld:pubmed |
pubmed-article:21749389 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21749389 | pubmed:articleTitle | Sphingosine-1-phosphate decreases melanin synthesis via microphthalmia-associated transcription factor phosphorylation through the S1P3 receptor subtype. | lld:pubmed |
pubmed-article:21749389 | pubmed:affiliation | Department of Biochemistry, College of Medicine, Chung-Ang University, Heukseok-Dong Dongjak-Gu, Seoul, Korea. | lld:pubmed |
pubmed-article:21749389 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21749389 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |